Development of Natural-Product-Inspired ABCB1 Inhibitors Through Regioselective Tryptophan C3-Benzylation

Rajesh Viswanathan,Dona Mariya Vincent,Habib Mostafa,Anza Suneer,Sabhashina Radha Krishnan,Mingmin Ong,Yoko Itahana,Koji Itahana

DOI: https://doi.org/10.1002/chem.202401782

2024-08-27

Chemistry

Abstract:The emergence of drug resistance in cancer is a serious threat. Upregulation of ABC/P-gp transporters significantly contributes to this emergence. Despite 30 years of efforts, the search for effective ABC/P-gp inhibitors with minimal toxicity to human cells, is still underway. Inspired by Nocardioazine A, a marine alkaloid that inhibits P-gp, we report a regioselective pathway to create indole-C3-benzyl cyclo-L-Trp-L-Trp DKPs. We have reported that exo-C3-N-Dbn--Trp2 (13) as a lead ABCB1 inhibitor that is more effective than Verapamil. C3N-Dbn-Trp2 restored chemotherapy sensitivity in drug-resistant human cancer cells and had no adverse effect on cell proliferation. Herein, we report several such C3-functionalized pyrroloindolines as ABCB1 inhibitors. Results arising from the molecular docking studies indicate that the interactions at the access tunnel between ABCB1 and the inhibitor result in a powerful predictor for the efficacy of the inhibitor. Based on fluorescence-based assays, we conclude that the most efficacious inhibitor is the p-cyano-derived exo-C3-N-Dbn--Trp2 (33a), closely followed by several analogues. We correlate that the predictions based on the inhibitor interactions at the access tunnel provide clues about the design of improved ABCB1 inhibitors. This work lays the foundation for the design of a new class of inhibitors from a cyclo-L-Trp-L-Trp DKP scaffold.